Ascletis Pharma Inc. (HKG:1672)
Hong Kong
· Delayed Price · Currency is HKD 15.62
+0.89 (6.04%)
Mar 10, 2026, 11:44 AM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 15.63 billion as of March 9, 2026. Its market cap has increased by 304.14% in one year.
Market Cap
15.63B
Enterprise Value
13.66B
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.62
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 15.63B, a decrease of -0.38%. That is a compound annual growth rate of -0.05%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 15.44B |
| Ascentage Pharma Group International | 16.66B |
| Zai Lab | 17.13B |
| Everest Medicines | 12.98B |
| Guangzhou Innogen Pharmaceutical Group | 11.05B |
| Nanjing Leads Biolabs | 10.71B |
| HBM Holdings | 10.08B |
| Shanghai Haohai Biological Technology | 9.96B |